Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

NCT04896853 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Acute Respiratory Distress Syndrome
Influenza A
Metapneumovirus Pneumonia
Respiratory Syncytial Virus (RSV)

Interventions

BIOLOGICAL: ProTrans®

Sponsor

NextCell Pharma Ab

Collaborators

[object Object]